Qualisure News

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

Unique Thyroid Cancer Tests: New Hope Unveiled

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Oliver Bathe: Qualisure Diagnostics Developing State-Of-The-Art Diagnostic Tests That Help To Personalize Cancer Care

From doctor to entrepreneur – Oliver Bathe from Qualisure Diagnostics

Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022]

2022 American Thyroid Association – Dr. Oliver Bathe

Qualisure Diagnostics: An AICE-Validate Success Story

Precision Oncology Test Thyroid GuidePx® Now Available From Qualisure Diagnostics

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

The Technological Drivers Powering Precision Oncology

Unique Thyroid Cancer Tests: New Hope Unveiled

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer

Subscribe For Updates on Testing & Diagnostics

Sign up to receive updates from Qualisure regarding our latest developments in precision medicine tools.

First Name

Last Name

Email Address

Telephone

Organization

Country

I am a(n)

consent_sub

I consent to the use of my personal information for the purpose of receiving updates and communications about the latest developments in Precision Oncology.

Get Started

Thyroid GuidePx®

News

Investors